Biotech & Pharma
GTP Bioways invests €12M in two GMP biopharmaceutical production units
Toulouse, France, October 22, 2021 – GTP Bioways, a CDMO (Contract Development and Manufacturing Organization) specializing in the production of…
Biotech & Pharma
Minafin reorganizes to meet customer challenges in fine chemicals
Louvain-la-Neuve, Belgium, October 19, 2021 – The Minafin Group, a leading process developer and manufacturer of fine chemicals for the…
Biotech & Pharma
Advent France Biotechnology launches its second fund with a first close at €86M ($102M)
Paris, France, September 30, 2021 – Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces…
Biotech & Pharma
New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies
Villejuif, France, September 27, 2021 – Aglaia Therapeutics, a biotechnology startup developing promising new therapies that can overcome resistance to…
Biotech & Pharma
Banook Group acquires German counterpart nabios GmbH to become a European leader in cardiac safety services
Nancy (France), and Munich (Germany), September 23, 2021 – The Banook Group, specialized in cardiac safety, clinical imaging and endpoint…
Medical Devices
Hephaï receives 2021 Catalyst Award from US National Academy of Medicine for its unique digital education platform
Paris, France, September 22, 2021 – Hephaï, a French start-up developing an AI-based digital education platform, today announces that it…
Biotech & Pharma
L’AFSSI dresse l’état des lieux des services de R&D dans les sciences de la vie en France lors des 8e AFSSI...
Paris, le 21 septembre 2021 – L’AFSSI, Association Française des Sociétés de Services et d’Innovation pour les Sciences de la…
Biotech & Pharma
Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials
Nantes, France, September 21, 2021 – Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production…
Biotech & Pharma
Advent France Biotechnology crée Thabor Therapeutics et finance son amorçage
Paris, France, le 15 septembre 2021 – Advent France Biotechnology (AFB), société de capital-risque spécialisée dans l’amorçage en sciences de…